139 related articles for article (PubMed ID: 36760869)
1. EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma.
Xu S; Ma B; Feng X; Yao C; Jian Y; Chen Y; Wang X; Xie H; Li L
Transl Androl Urol; 2023 Jan; 12(1):71-82. PubMed ID: 36760869
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma.
Ho TH; Kapur P; Eckel-Passow JE; Christie A; Joseph RW; Serie DJ; Cheville JC; Thompson RH; Homayoun F; Panwar V; Brugarolas J; Parker AS
J Clin Oncol; 2017 Nov; 35(32):3706-3713. PubMed ID: 28976794
[TBL] [Abstract][Full Text] [Related]
3. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
Zhang C; Li Z; Qi F; Hu X; Luo J
Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
[TBL] [Abstract][Full Text] [Related]
4. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of the prognostic value of the immune-related genes in clear cell renal cell carcinoma.
Liao Z; Yao H; Wei J; Feng Z; Chen W; Luo J; Chen X
Transl Androl Urol; 2021 Apr; 10(4):1607-1619. PubMed ID: 33968649
[TBL] [Abstract][Full Text] [Related]
6. A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients.
Shen C; Chen Z; Jiang J; Zhang Y; Xu W; Peng R; Zuo W; Jiang Q; Fan Y; Fang X; Zheng B
Front Genet; 2022; 13():1034567. PubMed ID: 36246657
[No Abstract] [Full Text] [Related]
7. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
Xie W; Xi P; Liu Y; Zhang Z; Sun T
Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
[No Abstract] [Full Text] [Related]
8. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
[TBL] [Abstract][Full Text] [Related]
9.
Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
[TBL] [Abstract][Full Text] [Related]
10. Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma.
Li CS; Lu ZZ; Fang DL; Zhou WJ; Wei J
Transl Androl Urol; 2021 Jun; 10(6):2478-2492. PubMed ID: 34295734
[TBL] [Abstract][Full Text] [Related]
11. Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration.
Xing Q; Jiaochen Luan ; Shouyong Liu ; Limin Ma ; Wang Y
Bosn J Basic Med Sci; 2022 Jun; 22(3):435-452. PubMed ID: 34420511
[TBL] [Abstract][Full Text] [Related]
12. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration.
Fan K; Zhang CL; Zhang BH; Gao MQ; Sun YC
Sci Rep; 2022 Oct; 12(1):16583. PubMed ID: 36195655
[TBL] [Abstract][Full Text] [Related]
14. Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Zheng Y; Wen Y; Cao H; Gu Y; Yan L; Wang Y; Wang L; Zhang L; Shao F
Onco Targets Ther; 2021; 14():2085-2100. PubMed ID: 33790572
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
16. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
17. Identifying Hypoxia Characteristics to Stratify Prognosis and Assess the Tumor Immune Microenvironment in Renal Cell Carcinoma.
Zhang Z; Li Q; Wang F; Ma B; Meng Y; Zhang Q
Front Genet; 2021; 12():606816. PubMed ID: 34194463
[No Abstract] [Full Text] [Related]
18. Identification of a novel immune-related microRNA prognostic model in clear cell renal cell carcinoma.
Guo Y; Li X; Zheng J; Fang J; Pan G; Chen Z
Transl Androl Urol; 2021 Feb; 10(2):888-899. PubMed ID: 33718090
[TBL] [Abstract][Full Text] [Related]
19. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
20. Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Chen M; Zhang S; Nie Z; Wen X; Gao Y
Front Oncol; 2020; 10():873. PubMed ID: 32547955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]